| ADCs | Antibody-Drug Conjugates |
| ADT | Androgen Deprivation Therapy |
| Ala | Alanine |
| BBB | Blood–Bain–Barrier |
| Cit | Citrulline |
| DAR | Drug-Antibody Ratio |
| DDI | Drug-Drug Interactions |
| DIO | Diet-Induced Obese |
| DOTA | 1,4,7,10-Tetraazacyclododeane |
| DPP4 | Dipeptidyl Peptidase 4 |
| DTNP | 5,5′-Disulfanediylbis(2-nitrobenzoic acid) or Ellman’s reagent |
| GHIH | Growth Hormone-Inhibiting Hormone |
| GIP | Gastric Inhibitory Polypeptide |
| GLP-1 | Glucagon-Like Peptide 1 |
| GLP-2 | Glucagon-Like Peptide 2 |
| gGlu | gamma glutamic acid |
| GnRH | Gonadotropin-Releasing Hormone |
| LHRH | Luteinizing Hormone-Releasing Hormone |
| LRP1 | Low-Density Lipoprotein Receptor-Related Protein 1 |
| NSCLC | Non-Small Cell Lung Cancer |
| PABC | p-Aminobenzyl Carbamate |
| PRRT | Peptide Receptor Radionuclide Therapy |
| PSMA | Prostate Specific Membrane Antigen |
| PTH | Parathyroid Hormone |
| SERCA | the Sarco/Endoplasmic Reticulum Calcium ATPase |
| SSTR | Somatostatin Receptor |